Home / Pharmaceutical company intelligence
Pharmaceutical company intelligence

W. Woodward Pakistan (Pvt) Ltd.

Private pharmaceutical manufacturer · Karachi · Pakistan

Pakistan pharmaceutical manufacturer with established branded-medicine operations.

Sourced corporate profile Corporate identity fields are source-tracked; portfolio, price and competitor intelligence remains independently calculated by MedInfoBase.
ShareSend this page
Evidence & freshness

What is sourced, and how recent is it?

Public-source corporate details
Latest regulatory-source observation23 Sep 2026Newest linked source record observed by MedInfoBase
Latest portfolio source check22 Sep 2026Latest source-check date across this published portfolio
Latest effective price date19 Aug 2026Newest effective date among published current price records
Corporate profile evidence1 sourceCorporate source details checked 16 Aug 2026

Regulatory-source portfolio data and company-supplied/corporate profile fields are tracked separately. Company claim/verification status is separate from source quality. An unclaimed company can still have a fully official-source-observed portfolio.

Regulatory & corporate identity

Company profile

Public-source corporate details
Legal / official name
W. Woodward Pakistan (Pvt.) Ltd.
Company type
Private pharmaceutical manufacturer
Corporate source details checked
16 Aug 2026
Corporate profile completeness
38%
DRAP manufacturing licenceAs published by the DRAP Licensing Division. DRAP issues this list for stakeholder review and states it is not a reference for litigation, claims or citation.
Formulation 000042 W.Woodward Pakistan Ltd. · Sindh
Source-linked licence identifiersShown as recorded in linked source rows; not a claim of current validity.
DML 000042 36 linked products · source seen 23 Sep 2026 View source ↗
Corporate profile source ledger Profile Source Url source ↗
Location intelligence

Company location

Google Maps
Exact site not yet sourced

No exact premises location is published without a defensible source.

Open in Google Maps ↗ The Google Maps search link uses the company name and available city/country context; it is not presented as a verified premises pin.
Intelligence snapshot

Portfolio at a glance

Not sales data · published MedInfoBase database view
Rx36public portfolio records represented
REG34unique registrations represented
IDX36indexed MedInfoBase presentations
SRC0additional source-observed presentations
R+0registry-only registrations
VER0registry-verified exact registrations
PKR35current validated price records
G16generic molecules in indexed catalogue
DF7dosage-form groups
TA6therapeutic areas
How to read these counts

RegistrationA unique regulatory registration number. One registration may have more than one strength/form/pack presentation.

PresentationA distinct medicine presentation, such as a particular strength, dosage form and pack.

IndexedA canonical MedInfoBase presentation that passed MedInfoBase identity and publication controls.

Source observedAn additional presentation observed in an official DRAP source but not counted as an indexed MedInfoBase presentation.

Registry onlyAn exact registry-verified registration not otherwise represented by an indexed or source-observed presentation.

Registry verifiedAn exact registration match found in an official DRAP registry source. This is evidence status, not a commercial ranking.

Data coverage

How complete is this profile?

Current price coverage97%
public portfolio presentations with a validated current price
Official-source coverage100%
products linked back to a source record
Unit-price parse coverage100%
priced packs safely normalized per unit
Comparable-market coverage92%
products with at least one like-for-like comparator
Therapeutic classification100%
products assigned to a broad therapeutic area
Visual intelligence

Downloadable company intelligence charts

Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.

Shareable intelligence

Therapeutic Portfolio Mix

Shows where the company portfolio is concentrated across broad therapeutic areas.

Therapeutic Portfolio MixW. Woodward Pakistan (Pvt) Ltd.Share of current product presentations by broad therapeutic areaMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/w-woodward-pakistan-pvt-ltdGenerated 24 Sep 2026Anti-infectives21 · 58%Pain & musculoskeletal9 · 25%Respiratory & allergy2 · 6%Cardiovascular2 · 6%Fluids & supportive care1 · 3%CNS & mental health1 · 3%Percentages are based on current product presentations in the MedInfoBase company portfolio.

Portfolio distribution, not sales or market-share data.

Shareable intelligence

Dosage Form Portfolio

Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.

Dosage Form PortfolioW. Woodward Pakistan (Pvt) Ltd.Distribution of current product presentations by normalized dosage formMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/w-woodward-pakistan-pvt-ltdGenerated 24 Sep 202636presentationsTablet14 · 39%Suspension9 · 25%Capsule5 · 14%Cream5 · 14%Gel1 · 3%Sachet1 · 3%Other forms1 · 3%Dosage-form wording is normalized for intelligence display; original source wording remains preserved in product records.

Counts are product presentations, not production or sales volumes.

Shareable intelligence

Equivalent Price Position

Shows whether safely comparable products are below, near or above the peer median unit price.

Equivalent Price PositionW. Woodward Pakistan (Pvt) Ltd.Current company products compared with like-for-like equivalent medicines using normalized unit pricesMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/w-woodward-pakistan-pvt-ltdGenerated 24 Sep 202633comparable productsBelow peer median4 · 12%Near peer median15 · 45%Above peer median14 · 42%Company median price position+4.9%Lowest-price equivalents1Method: same generic + stated strength + dosage form + compatible unit basis; pack prices normalized per unit.

This is price-position intelligence, not sales, demand or market-share data.

Shareable intelligence

Closest Portfolio Competitors

Highlights other manufacturers with the greatest generic overlap with this company portfolio.

Closest Portfolio CompetitorsW. Woodward Pakistan (Pvt) Ltd.Companies with the largest number of shared generic medicines in the MedInfoBase databaseMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/w-woodward-pakistan-pvt-ltdGenerated 24 Sep 2026Nabiqasim Industries (Pvt) Ltd.,14 shared88% overlapAtco Laboratories Limited13 shared81% overlapValor Pharmaceuticals13 shared81% overlapMedisure Laboratories Pakistan Pvt …13 shared81% overlapWelmed Pharmaceutical Industries (P…12 shared75% overlapPharmasol (Pvt) Ltd.11 shared69% overlapPortfolio overlap measures shared generics only; it is not a measure of market share, affiliation or sales competition.

Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.

Portfolio intelligence

Therapeutic areas

Broad portfolio view

High-level clinical areas represented by this company’s current MedInfoBase portfolio.

Anti-infectives21 products · 58%
Pain & musculoskeletal9 products · 25%
Respiratory & allergy2 products · 6%
Cardiovascular2 products · 6%
Fluids & supportive care1 products · 3%
CNS & mental health1 products · 3%
Pharmacological detail

Drug classes

More specific view

More specific classes derived from the canonical generic and preserved curated classifications.

Analgesics / NSAIDs9 products · 25%
Antifungals5 products · 14%
Third-generation cephalosporins4 products · 11%
Fluoroquinolone antibacterials3 products · 8%
Antimalarials3 products · 8%
Macrolide antibacterials3 products · 8%
Antihistamines2 products · 6%
HMG-CoA reductase inhibitors2 products · 6%
Formulation footprint

Dosage forms

Tablet14 products
Suspension9 products
Capsule5 products
Cream5 products
Gel1 products
Sachet1 products
Syrup1 products
How MedInfoBase classifies the portfolio

MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.

Portfolio leaders

Deepest brand families

Ranked by registered presentations · not sales
#1 ArtelumArtemether + Lumefantrine 3presentations 20 mg + 120 mg, 240 mg + 240 mg, 80 mg + 480 mg · Tablet #2 RuberinIbuprofen 3presentations 100 mg/5 mL, 200 mg, 400 mg · Suspension, Tablet #3 TempolParacetamol 3presentations 120 mg/5 mL, 250 mg/5 mL, 500 mg · Suspension, Tablet #4 Allerwood AllerwoodLoratadine 2presentations 10 mg, 5 mg/5 mL · Tablet, Syrup #5 Atvast AtvastAtorvastatin 2presentations 10 mg, 20 mg · Tablet #6 BactizithAzithromycin 2presentations 200 mg/5 mL, 500 mg · Suspension, Capsule
Price intelligence

Unit-price positioning vs equivalent products

Same generic + strength + form + unit basis
Below market median412% of comparable products
Near market median15within ±5% of median
Above market median1442% of comparable products
Lowest-price equivalents1ties included
Company median price position +4.9% relative to the median unit price of like-for-like equivalent products.
Most competitively positioned examplesProducts with at least 3 market comparators
Orawood Oral 20 mg/gMiconazole · Gel · 20gm PKR 6.45/g-26.0% vs market median Ruberin 200 mgIbuprofen · Tablet · 500’s PKR 1.89/tablet-18.4% vs market median Terbiwood Terbiwood 1ch gm 1 %Terbinafine · Cream · 10gm PKR 25.81/g-12.3% vs market median Ruberin 400 mgIbuprofen · Tablet · 250’s PKR 3.16/tablet-9.9% vs market median Vermol 100 mgMebendazole · Tablet · 60’s PKR 6.58/tablet-4.3% vs market median
How MedInfoBase calculates price position

Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.

Competitive landscape

Portfolio overlap

Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.

Nabiqasim Industries (Pvt) Ltd.,365 products · 118 generics 14shared generics Atco Laboratories Limited278 products · 94 generics 13shared generics Valor Pharmaceuticals219 products · 97 generics 13shared generics Medisure Laboratories Pakistan Pvt Ltd120 products · 56 generics 13shared generics Welmed Pharmaceutical Industries (Pvt) Ltd.65 products · 32 generics 12shared generics Pharmasol (Pvt) Ltd.257 products · 102 generics 11shared generics
Regulatory & price activity

Observed database signals

Indexed registration numbers34Distinct registrations among indexed, published, presentation-validated products only
Verified price observations70
Products with a verified price36
Products with multiple price observations34
Source records with multiple versions36
Latest portfolio source check22 Sep 2026
Latest effective price date19 Aug 2026
Latest source observation23 Sep 2026

These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.

Company medicine portfolio

Medicine portfolio

34 unique registration(s) · 36 indexed presentation(s)

This unified portfolio keeps three evidence lanes distinct: indexed MedInfoBase presentations, additional source-observed presentations, and registry-only registrations that are not otherwise represented. A registration number is not the same thing as a presentation, and source-observed rows are not counted as indexed. Source-only rows with a strength/form/pack contradiction remain visible as evidence but the conflicting field is held for normalization.

Reset
BrandGenericStrengthFormPackRegistrationSource-listed priceUnit pricePrice position
Acflox Acflox Moxifloxacin 400 mg Tablet 5's 067237 PKR 988.30 PKR 197.66/tablet 7% above median
Allerwood Allerwood Loratadine 10 mg Tablet 10's 023772 PKR 160.81 PKR 16.08/tablet 12% above median
Allerwood Allerwood Loratadine 5 mg/5 mL Syrup 60ml 023773 PKR 135.90 PKR 2.27/mL 34% above median
Artelum Artemether + Lumefantrine 20 mg + 120 mg Tablet 16's 039111 PKR 643.28 PKR 40.21/tablet Near median
Artelum Artemether + Lumefantrine 240 mg + 240 mg Tablet 8's 050456 PKR 530.70 PKR 66.34/tablet Near median
Artelum Artemether + Lumefantrine 80 mg + 480 mg Tablet 6's 061608 PKR 629.20 PKR 104.87/tablet Near median
Atvast Atvast Atorvastatin 10 mg Tablet 10’s 032065 PKR 288.48 PKR 28.85/tablet Near median
Atvast Atvast Atorvastatin 20 mg Tablet 10’s 032066 PKR 561.69 PKR 56.17/tablet 20% above median
Bactizith Azithromycin 200 mg/5 mL Suspension 15ml 024195 PKR 356.62 PKR 23.77/mL 9% above median
Bactizith Azithromycin 500 mg Capsule 3's 055717 PKR 254.74 PKR 84.91/capsule Near median
Bactizith Bactizith Azithromycin 250 mg Capsule 10's 024196 PKR 652.18 PKR 65.22/capsule 32% above median
Dermizole Dermizole 2ch gm Miconazole 2 % Cream 10gm 048616 PKR 91.10 PKR 9.11/g 34% above median
Effiquin Levofloxacin 250 mg Tablet 10's 050457 PKR 502.56 PKR 50.26/tablet Near median
Effiquin Levofloxacin 500 mg Tablet 10's 050458 PKR 836.27 PKR 83.63/tablet 6% above median
Gimz Clotrimazole 100 mg/g (10%) Vaginal cream 5gm 048617 PKR 167.01 PKR 33.40/g 20% above median
Ocin Mupirocin 2% Cream 15gm 053465 PKR 257.10 PKR 17.14/g Near median
Orawood Oral Miconazole 20 mg/g Gel 20gm 048615 PKR 129.05 PKR 6.45/g 26% below median
Paedicare 90 Oral rehydration salts (ORS) NaCl 1.3 g + KCl 0.75 g + trisodium citrate dihydrate 1.45 g + glucose anhydrous 6.75 g / sachet Sachet 1's 011209 PKR 10.15 PKR 10.15/sachet No comparator
Phloxetin Phloxetin Fluoxetine 20 mg Capsule 10’s 024197 PKR 136.65 PKR 13.67/capsule 5% above median
Ruberin Ibuprofen 100 mg/5 mL Suspension 90ml 011625 PKR 83.05 PKR 0.92/mL Near median
Ruberin Ibuprofen 200 mg Tablet 500’s 023777 PKR 942.94 PKR 1.89/tablet 18% below median
Ruberin Ibuprofen 400 mg Tablet 250’s 023778 PKR 790.31 PKR 3.16/tablet 10% below median
Tempol Paracetamol 120 mg/5 mL Suspension 60ml 002991 PKR 66.01 PKR 1.10/mL Near median
Tempol Paracetamol 250 mg/5 mL Suspension 60ml 022447 PKR 94.97 PKR 1.58/mL Near median
Tempol Paracetamol 500 mg Tablet 200’s 023779 PKR 705.01 PKR 3.53/tablet Near median
Tempol 6+ Tempol 6+ Paracetamol 250 mg Suspension 100ml 022447 PKR 106.86 PKR 1.07/mL No comparator
Tempol 6+ Tempol 6+ Paracetamol 100 mg/mL Suspension 15ml 022448 PKR 52.13 PKR 3.48/mL No comparator
Tempol Tempol Paracetamol 120 mg Suspension 100ml 002991 PKR 100.88 PKR 1.01/mL Near median
Terbiwood Terbiwood 1ch gm Terbinafine 1 % Cream 10gm 055744 PKR 258.11 PKR 25.81/g 12% below median
Vagican Vaginal Miconazole 20 mg/g Vaginal cream 20gm 048613 PKR 129.05 PKR 6.45/g 11% above median
Vermol Mebendazole 100 mg Tablet 60’s 023775 PKR 394.76 PKR 6.58/tablet Near median
Vermol SD Mebendazole 500 mg Tablet 1's 028692 PKR 43.22 PKR 43.22/tablet 29% above median
Waybac Dry Cefixime 100 mg/5 mL Dry suspension 30ml 050461 PKR 330.39 PKR 11.01/mL 5% above median
Waybac DS Dry Cefixime 200 mg/5 mL Dry suspension 30ml 050462 PKR 404.33 PKR 13.48/mL Near median
Waybac Waybac Cefixime 400 mg Capsule 5's 050460 PKR 592.03 PKR 118.41/capsule Near median
Waybac Waybac Cefixime 200 mg Capsule 5's 067030 PKR 331.70 PKR 66.34/capsule 6% above median
MedInfoBase company-intelligence methodology

This page is generated from MedInfoBase medicine, generic, company, price and official-source records. Unverified third-party discovery records are retained internally for coverage auditing and are not published as company registrations. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official-source prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.

Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.

Cite this record

Manufacturer record
MedInfoBase. (2026). W. Woodward Pakistan (Pvt) Ltd — registered product portfolio in Pakistan [Data set]. MedInfoBase. Retrieved September 24, 2026, from https://medinfobase.com/company/w-woodward-pakistan-pvt-ltd/
Download .RIS Download .BIB EndNote, Zotero, Mendeley, RefWorks

Records change over time. Please cite the access date so readers can locate the version you used.